A photoactivatable glutathione-drug conjugate S-35-labeled-azidophenacyl-gl
utathione (APA-SG) was synthesized and used to identify protein(s) involved
in recognition and/or transport of glutathione conjugates of electrophilic
drug species. A similar to 460-kDa protein was found to be highly labeled
by S-35-labeled APA-SG in an Adriamycin-resistant HL-60 (HL-60/ADR) cell li
ne and identified as the catalytic subunit of DNA-dependent protein kinase
(DNA-PKcs) by amino acid sequence analysis, Western blot, and immunoprecipi
tation with specific antibodies. Binding specificity was confirmed by compe
tition isotope dilution assays with purified proteins. A 15- to 20-fold inc
rease in DNA-PKcs expression in the HL-60/ADR cell line was accompanied by
an equivalent increase in 35S-labeled APA-SG binding. APA-SG, along with ot
her glutathione conjugates and analogs inhibited the DNA-PK-mediated phosph
orylation of an in vitro peptide substrate in a concentration-dependent man
ner. Using different antibodies to immunoprecipitate the individual compone
nts of the DNA-PK complex (DNA-PKcs, Ku70, and Ku80), it was shown that APA
-SG caused a destabilization of the trimeric holoenzyme complex by dissocia
ting the catalytic subunit from the Ku heterodimer. These data suggest that
the kinase-mediated signaling is inhibited when glutathione conjugates bin
d to DNA-PKcs and may also indicate a possible strategy for design of novel
DNA-PK inhibitors.